Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis.
Expert Rev Pharmacoecon Outcomes Res
; 16(2): 153-66, 2016.
Article
in En
| MEDLINE
| ID: mdl-26681527
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Dermatologic Agents
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Health_economic_evaluation
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Expert Rev Pharmacoecon Outcomes Res
Journal subject:
FARMACOLOGIA
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: